Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)
Clinical trial NCT06844422 · RECRUITING
Trial details
- NCT number
- NCT06844422
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-08
- Primary completion
- 2028-02-18
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.